Guilin Tang

Guilin Tang, M.D., Ph.D., FACMG is a Professor in the Department of Hematopathology, Division of Pathology-Lab Medicine, and also holds a professorship in the School of Health Professions at The University of Texas MD Anderson Cancer Center in Houston, TX. He serves as Section Chief of the Clinical Cytogenetics Laboratory and Adjunct Medical Director, demonstrating leadership in both clinical and academic domains.

His research focuses on the characterization and risk stratification of cytogenetic abnormalities in hematological malignancies, including leukemias and lymphomas. He is particularly interested in discovering novel cytogenetic abnormalities and understanding their clinicopathologic correlations, as well as studying indolent cytogenetic clones that emerge after cytotoxic therapies.

Dr. Tang is actively engaged in clinical diagnostics and research at one of the leading cancer centers in the world. His work bridges laboratory medicine with patient care, contributing to precision oncology through advanced cytogenetic analysis. While specific publications and awards are not listed in the provided text, his role suggests significant contributions to the field of hematopathology and molecular diagnostics.

• Section Chief, Clinical Cytogenetics, Department of Hematopathology
• Adjunct Medical Director, School of Health Professions

Dr. Tang advises trainees and leads a clinical laboratory team focused on cytogenetic diagnostics. He likely participates in grant-funded research, though specific grants are not detailed. His leadership roles indicate active mentorship and program development within MD Anderson’s academic and clinical training frameworks.

He is part of specialized research and clinical teams within the Department of Hematopathology, contributing to patient care, innovation in diagnostic methods, and translational research in cancer genomics.